📈 #ATOMUSDT Trade Setup 🚀 $ATOM

Irma - Feb 28 - - Dev Community

📊 In the Uptrend lane! After breaking above the $10 resistance, the price signals a resumption of the uptrend, eyeing +20% gains to $12 in the near term. SL set at $8.90.

📈 Trend: Uptrend (ST, MT, LT)

🚀 Momentum: Bullish. MACD Line > Signal Line, RSI > 55.

🔍 Supp/Res: $10.00 (prev. resistance), $8.50 / $12.00

🚨 Set alerts & manage risk!

🎯 Buy Signal: Break above $10 (Uptrend resumption)
🎯 Sell Target: $12.00 (Near-term upside)
🛑 Stop Loss: $8.90

Image description

Image
MS Project vs Other Tools: Quick Comparison of Robust Project Management Solutions

projectmanagement, project, software, pmtools
Image
Home economic effect of road traffic injury compared to schedule crisis situations in the low-income region.
Image
Aftereffect of Tafamidis on Serum Transthyretin Levels inside Non-Trial People Along with Transthyretin Amyloid Cardiomyopathy.
Image
Will Couch of Surgery Gender Impact Divisional or perhaps Residency Program Movie director Sex Selection?
Image
Web3 and the Decentralized Internet: What’s Next for Developers?

web3, beginners, blockchain, developers
Image
Oromandibular Dystonia: A Clinical Examination of A couple of,020 Situations.
Image
Clinical characteristics, administration, along with result of hemodialysis patients along with SARS-CoV-2.
Image
vnsport online
Image
Persistent angiosarcoma associated with crown using opsoclonus myoclonus affliction: position of save you therapy.
Image
Data Types In Python

python, interview, programming, beginners
Image
dompdf page numbering and cover image for html content exceeding one print page.
Image
CDR1 Arrangement Can impact Nanobody Recombinant Appearance Produces.
Image
Scaling Node.js Applications: Strategies and Best Practices

webdev, javascript, beginners, node
Image
The Future of AI Writing
Image
Decreasing the actual causality involving time string.
Image
Committing suicide within anaesthetists: an organized evaluate.
Image
[Actual utilization of direct mouth anticoagulants throughout venous thromboembolic disease].
Image
TVP - Thinnest Viable Platform

devops, tvp, testing, beginners
Image
Pulmonary dry natural powder vaccine of pneumococcal antigen packed nanoparticles.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .